VEGFA and myocardial infarction: Likewise, the in vivo administration of hypoxia-inducible VEGF-engineered MSCs was shown to induce ischemia-responsive VEGF production and lead to a significant increase in myocardial neovascularization after myocardial infarction in rats (39).